Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psoriasis
C.E.M. Griffiths, April W. Armstrong, Jóhann E. Guðjónsson, et al.
The Lancet (2021) Vol. 397, Iss. 10281, pp. 1301-1315
Closed Access | Times Cited: 1461

Showing 1-25 of 1461 citing articles:

Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Xue Zhou, Youdong Chen, Lian Cui, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 343
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K. Mahil, Katie Bechman, Antony Raharja, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 9, pp. e627-e637
Open Access | Times Cited: 162
Skin Barrier Dysregulation in Psoriasis
Andreas Orsmond, Lara Bereza-Malcolm, Tom Lynch, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10841-10841
Open Access | Times Cited: 132
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 132
Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases Treatment
Fang Xu, Ziying Fei, Huaxing Dai, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 122
Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis
Feiyang Ma, Olesya Plazyo, Allison C. Billi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 120
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 113
Challenges and Future Trends in the Treatment of Psoriasis
Hyun Ji Lee, Miri Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13313-13313
Open Access | Times Cited: 108
Reactive Oxygen Species-Responsive Gel-Based Microneedle Patches for Prolonged and Intelligent Psoriasis Management
Duohang Bi, Fei Qu, Wanyue Xiao, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4346-4357
Closed Access | Times Cited: 82
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
Mihaela Simona Popoviciu, Nirja Kaka, Yashendra Sethi, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 422-422
Open Access | Times Cited: 76
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
Ana Gabriela Barros Peláez, Pablo Durán, Ivana Vera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7499-7499
Open Access | Times Cited: 74
Tailoring Hyaluronic Acid Hydrogels for Biomedical Applications
Zhiqiang Luo, Yu Wang, Jinbo Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 49
Closed Access | Times Cited: 73
Advances in the study of macrophage polarization in inflammatory immune skin diseases
Tingting Xia, Sheng-Ping Fu, Ruilin Yang, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 53
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 52
Single-atom catalysts-based catalytic ROS clearance for efficient psoriasis treatment and relapse prevention via restoring ESR1
Xiangyu Lu, Le Kuai, Fang Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 52
The burden of skin and subcutaneous diseases: findings from the global burden of disease study 2019
Aobuliaximu Yakupu, Rehanguli Aimaier, Bo Yuan, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 50
Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
Nicolò Costantino Brembilla, Wolf‐­Henning Boehncke
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas Bieber
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 662-680
Closed Access | Times Cited: 44
Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES
Rui Ma, Lian Cui, Jiangluyi Cai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 36
Triggers for the onset and recurrence of psoriasis: a review and update
Suwen Liu, M. L. He, Jian Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 35
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K. Ferris, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 510-521
Closed Access | Times Cited: 31
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 22
Therapeutic application of circular RNA aptamers in a mouse model of psoriasis
Si-Kun Guo, Chu‐Xiao Liu, Yi-Feng Xu, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 21
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials
Liuting Zeng, Kailin Yang, Qi He, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top